Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane Lung Protection During NEC Surgery in Neonates
ChiCTR2500107248Phase 4Not yet recruiting
- Sponsor
- Chongqing Health Center for Women and Children
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of sevoflurane in necrotizing enterocolitis (NEC) (2 arms), sponsored by Chongqing Health Center for Women and Children. Primary endpoint: Inflammatory markers in postoperative bronchoalveolar lavage fluid. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
sevoflurane
03
Conditions
necrotizing enterocolitis (NEC)
Beyond the preview
Go deeper on ChiCTR2500107248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500107248.